𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line

✍ Scribed by M. P. Polo; R. Crespo; M. G. de Bravo

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
495 KB
Volume
29
Category
Article
ISSN
0263-6484

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antisense inhibition of urokinase: Effec
Antisense inhibition of urokinase: Effect on malignancy in a human osteosarcoma cell line
✍ Carsten Haeckel; Sabine Krueger; Albert Roessner πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 251 KB πŸ‘ 2 views

Expression of urokinase-type plasminogen activator (u-PA) strongly correlates with a malignant tumor cell phenotype. In the multistep process of metastasis, different cellular functions are influenced by urokinase. The enzyme is known to be effective via both proteolytical and signal transduction me

Effect of simvastatin, an inhibitor of h
Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme a reductase, on the growth of human ito cells
✍ Ariane Mallat; Anne-Marie Preaux; Sylvie Blazejewski; Daniel Dhumeaux; Jean Rose πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 685 KB

During hepatic fibrogenesis, Ito cells proliferate, acquire a myofibroblastlike phenotype and synthesize increased amounts of extracellular matrix components. In this study, we have assessed the effects of simvastatin, an inhibitor of hydroxy-methylglutaryl-coenzyme A reductase, on the growth of hum

Synergistic antiproliferative and apopto
Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines
✍ Murielle Mimeault; Nicole Pommery; Jean-Pierre HΓ©nichart πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 435 KB πŸ‘ 1 views

## Abstract Our results revealed that the blockade of epidermal growth factor receptor (EGFR) tyrosine kinase and protein kinase A (PKA) signaling pathways by specific inhibitors (PD153035 and Rp‐cAMPs) leads to a synergistic inhibition of EGF‐ and serum‐stimulated growth of human prostatic cancer